BRPI0924981A2 - vacinas para câncer cervical. - Google Patents

vacinas para câncer cervical.

Info

Publication number: BRPI0924981A2
Authority: BR; Brazil
Prior art keywords: cervical cancer; cancer vaccines; vaccines; cervical; cancer
Prior art date: 2009-06-19

Application number

BRPI0924981A

Other languages

English (en)

Inventor

Hyoung Jin Kin

Jin-Wook Jang

Kong-Jin Kim

Kwang Sung Kim

Na Gyong Lee

Yang-Je Cho

Original Assignee

Eyegene Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-19

Filing date

2009-10-20

Publication date

2016-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43356558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0924981(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-10-20 Application filed by Eyegene Inc filed Critical Eyegene Inc

2016-03-15 Publication of BRPI0924981A2 publication Critical patent/BRPI0924981A2/pt

2022-02-08 Publication of BRPI0924981B1 publication Critical patent/BRPI0924981B1/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

BRPI0924981-8A 2009-06-19 2009-10-20 Composição de vacina para câncer cervical BRPI0924981B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR20090055179		2009-06-19
KR10-2009-0055179		2009-06-19
PCT/KR2009/006062 WO2010147268A1 (ko)	2009-06-19	2009-10-20	자궁경부암 백신

Publications (2)

Publication Number	Publication Date
BRPI0924981A2 true BRPI0924981A2 (pt)	2016-03-15
BRPI0924981B1 BRPI0924981B1 (pt)	2022-02-08

Family

ID=43356558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0924981-8A BRPI0924981B1 (pt)	2009-06-19	2009-10-20	Composição de vacina para câncer cervical

Country Status (11)

Country	Link
US (1)	US9566323B2 (pt)
EP (1)	EP2444103B1 (pt)
JP (1)	JP5758385B2 (pt)
KR (3)	KR101181907B1 (pt)
CN (2)	CN104288763B (pt)
AU (1)	AU2009348078B2 (pt)
BR (1)	BRPI0924981B1 (pt)
MX (1)	MX2011013566A (pt)
PL (1)	PL2444103T3 (pt)
TR (1)	TR201802597T4 (pt)
WO (1)	WO2010147268A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7999085B2 (en) *	2007-01-09	2011-08-16	Bio-Rad Laboratories, Inc.	Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
KR20120068647A (ko) *	2010-12-18	2012-06-27	아이진 주식회사	개선된 면역반응을 유도하는 백신
EP2722389B1 (en) *	2011-06-15	2018-03-07	Hong Jin Kim	Method for enhancing the production yield of human papillomavirus l1 protein
US9771397B2 (en)	2011-12-01	2017-09-26	University Of Cape Town	HPV chimaeric particle
KR101452830B1 (ko) *	2012-04-06	2014-10-21	아이진 주식회사	두 가지 항암물질을 동시에 제공하는 대장균 균주
KR101559622B1 (ko) *	2012-07-30	2015-10-13	중앙대학교 산학협력단	인유두종바이러스 바이러스 유사입자의 고효율 정제방법
WO2014046410A1 (ko) *	2012-09-20	2014-03-27	중앙대학교 산학협력단	노다바이러스의 바이러스 유사입자의 생산방법, 이를 발현하는 효모 세포주 및 이를 포함하는 백신 조성물
KR20140060053A (ko) *	2012-11-09	2014-05-19	아이진 주식회사	인플루엔자 백신용 면역증강제
CN107002085A (zh) *	2014-09-11	2017-08-01	卡迪拉保健有限公司	具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗
CN107001430A (zh)	2014-10-24	2017-08-01	哈普威克斯有限责任公司	癌症和皮肤病变治疗
US10799574B2 (en)	2014-10-24	2020-10-13	Hpvvax. Llc	Method and composition for treating cancer or skin lesion using a vaccine
RU2677336C2 (ru) *	2014-12-26	2019-01-16	Айджин, Инк.	Способ получения вирусоподобных частиц папилломавируса человека
US10874733B2 (en)	2016-10-31	2020-12-29	Eyegene Inc.	Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same
US10918709B2 (en)	2016-10-31	2021-02-16	Eyegene Inc.	Immune modulator and vaccine composition containing the same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2194839T3 (es)	1991-07-19	2003-12-01	Univ Queensland	Vacuna de papilomavirus.
US5437951A (en)	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
US5618536A (en)	1992-09-03	1997-04-08	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric papillomavirus-like particles
ATE328068T1 (de) *	1994-05-16	2006-06-15	Merck & Co Inc	Papillomavirus vakzine
US5888516A (en)	1994-05-16	1999-03-30	Merck & Co. Inc.	Recombinant papillomavirus vaccines
AR004464A1 (es) *	1994-11-14	1998-12-16	Merck Sharp & Dohme	Un metodo para producir una proteina de capside de papilomavirus
US6685949B1 (en) *	1998-01-13	2004-02-03	The United States Of America As Represented By The Department Of Health & Human Services	Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
GB9907553D0 (en) *	1999-04-01	1999-05-26	Cantab Pharma Res	Purification of biological preparations
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
KR100423480B1 (ko) *	2001-11-20	2004-03-18	삼성전자주식회사	복수의 토너농도센서를 가지는 프린터 및 그의토너공급제어방법
KR100456681B1 (ko)	2002-05-22	2004-11-10	주식회사 대웅	박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
SI1572233T1 (sl) *	2002-12-20	2011-07-29	Glaxosmithkline Biolog Sa	Uporaba HPV16 in HPV18 kot cepivo proti enemu ali več onkogenih HPV tipa 31,33,35,39,45,51,52,56,58,59,66,68
PT1572233E (pt) *	2002-12-20	2011-06-07	Glaxosmithkline Biolog Sa	Utilização de hpv16 e hpv18 como vacina contra um ou mais de tipos de hpv oncogénicos 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
US7368537B2 (en) *	2003-07-15	2008-05-06	Id Biomedical Corporation Of Quebec	Subunit vaccine against respiratory syncytial virus infection
MY140664A (en)	2003-09-29	2010-01-15	Merck Sharp & Dohme	Optimized expression of hpv 45 l1 in yeast
GB0323965D0 (en) *	2003-10-13	2003-11-19	Glaxosmithkline Biolog Sa	Immunogenic compositions
GB0323968D0 (en) *	2003-10-13	2003-11-19	Glaxosmithkline Biolog Sa	Immunogenic compositions
JP2008502633A (ja) *	2004-06-16	2008-01-31	グラクソスミスクラインバイオロジカルズソシエテアノニム	Ｈｐｖ１６およびｈｐｖ１８ならびにｈｐｖ３１、４５または５２から選ばれる少なくとも１つの別のｈｐｖ型に対するワクチン
AR053715A1 (es) *	2005-04-26	2007-05-16	Glaxosmithkline Biolog Sa	Vacuna multivalente de vph
WO2006114312A2 (en) *	2005-04-26	2006-11-02	Glaxosmithkline Biologicals S.A.	Vaccine
KR100740237B1 (ko)	2005-05-10	2007-07-18	아이진 주식회사	올리고뉴클레오타이드 및 비독성 다당체를 포함하는면역보조제
JP2008540625A (ja) *	2005-05-19	2008-11-20	グラクソスミスクラインバイオロジカルズソシエテアノニム	Ｅ．ｃｏｌｉ易熱性毒素のＢ−サブユニット、抗原およびアジュバントを含むワクチン組成物
BRPI0611336A2 (pt) *	2005-06-01	2010-08-31	Dow Global Technologies Inc	método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina
TWI457133B (zh) *	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
WO2007089051A1 (en) *	2006-02-01	2007-08-09	Eyegene Inc.	Composition for treating cancer comprising oligonucleotide and non-toxic lps

2009
- 2009-10-20 CN CN201410444512.7A patent/CN104288763B/zh not_active Expired - Fee Related
- 2009-10-20 WO PCT/KR2009/006062 patent/WO2010147268A1/ko not_active Ceased
- 2009-10-20 EP EP09846240.1A patent/EP2444103B1/en active Active
- 2009-10-20 PL PL09846240T patent/PL2444103T3/pl unknown
- 2009-10-20 US US13/379,212 patent/US9566323B2/en not_active Expired - Fee Related
- 2009-10-20 JP JP2012515957A patent/JP5758385B2/ja not_active Expired - Fee Related
- 2009-10-20 MX MX2011013566A patent/MX2011013566A/es active IP Right Grant
- 2009-10-20 TR TR2018/02597T patent/TR201802597T4/tr unknown
- 2009-10-20 BR BRPI0924981-8A patent/BRPI0924981B1/pt not_active IP Right Cessation
- 2009-10-20 KR KR1020090099982A patent/KR101181907B1/ko not_active Expired - Fee Related
- 2009-10-20 AU AU2009348078A patent/AU2009348078B2/en not_active Ceased
- 2009-10-20 CN CN200980111082.4A patent/CN102215861B/zh not_active Expired - Fee Related
2012
- 2012-07-13 KR KR1020120076878A patent/KR101345205B1/ko not_active Expired - Fee Related
2013
- 2013-07-08 KR KR1020130079935A patent/KR101595779B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2444103A4 (en)	2013-12-18
TR201802597T4 (tr)	2018-03-21
JP5758385B2 (ja)	2015-08-05
MX2011013566A (es)	2012-06-28
CN102215861B (zh)	2014-10-08
KR101345205B1 (ko)	2013-12-27
KR20120083263A (ko)	2012-07-25
BRPI0924981B1 (pt)	2022-02-08
US9566323B2 (en)	2017-02-14
PL2444103T3 (pl)	2018-05-30
KR101595779B1 (ko)	2016-02-19
KR20100136889A (ko)	2010-12-29
CN104288763A (zh)	2015-01-21
US20120100169A1 (en)	2012-04-26
EP2444103B1 (en)	2017-12-20
AU2009348078A1 (en)	2011-12-15
EP2444103A1 (en)	2012-04-25
AU2009348078B2 (en)	2013-03-14
CN104288763B (zh)	2018-03-06
JP2012530488A (ja)	2012-12-06
KR101181907B1 (ko)	2012-09-11
KR20130083426A (ko)	2013-07-22
CN102215861A (zh)	2011-10-12
WO2010147268A1 (ko)	2010-12-23

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-02	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2020-04-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-08-18	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-07-06	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-12-07	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2022-02-08	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.
2025-09-02	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: EXTINTA A PATENTE, NOS TERMOS DO ARTIGO 86, DA LPI, E ARTIGO 14 DA PORTARIA 52/2023, REFERENTE AO NAO RECOLHIMENTO DA 16A RETRIBUICAO ANUAL. PARA FINS DE RESTAURACAO CONFORME ARTIGO 87, DA LPI 9.279, E ARTIGO 15, DA PORTARIA 52/2023, VIDE PARECER.
2025-12-23	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2852 DE 02-09-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0924981A2 (pt)	2016-03-15	vacinas para câncer cervical.
BR112012004807A2 (pt)	2017-04-11	vacina para pcsk9
PT2456889E (pt)	2014-11-21	Marcadores para o cancro do endométrio
BRPI1010849A2 (pt)	2016-04-05	parafuso para ossos.
DK2200646T3 (da)	2013-10-21	RNA-Vacciner
BR112013012195A2 (pt)	2018-07-10	oligonucleotídeo imunoestimulatórios
FR2964987B1 (fr)	2012-10-05	Souffleur electroportatif.
BRPI1011309A2 (pt)	2016-03-15	suporte para cartões
BR112012001490A2 (pt)	2016-03-15	aparelho para alimentação.
GB0905570D0 (en)	2009-05-13	Combined vaccines
BR112012003287A2 (pt)	2016-03-01	implemento para cuidado oral.
DK2114993T3 (da)	2012-10-22	Vaccine
BRPI1014035A2 (pt)	2016-04-12	método para contracepção.
IT1396487B1 (it)	2012-12-14	Convogliatore.
EP2516629A4 (en)	2013-09-04	VACCINES AGAINST HERPES SIMPLEX VIRUS
GB201003293D0 (en)	2010-04-14	Cancer vaccine
BRPI1014031A2 (pt)	2018-02-20	vacinas de nanoemulsão
BR112012002612A2 (pt)	2018-03-13	calha.
BRPI0921578A2 (pt)	2019-09-24	vacinas unitemporais
FR2942385B1 (fr)	2015-06-19	Grille-pain.
IT1394641B1 (it)	2012-07-05	Struttura di rasoio perfezionato.
BR112012004276A2 (pt)	2017-10-24	adjuvante compreendendo alumínio, oligonucleotídeo e policátion
EP2411039A4 (en)	2015-05-06	Glycoconjugate VACCINES
BR112012000801A2 (pt)	2016-02-23	recipiente para medicamento
ES1073526Y (es)	2011-03-24	Almohada.